Tilray Brands, Inc. Finance Lease, Liability
Tilray Brands, Inc. (TLRY) had Finance Lease, Liability of $124.79 million as of 2026-05-31, per its 10-K filed 2026-07-28.
Financial Statements › Balance Sheet › Liabilities
us-gaap:FinanceLeaseLiability · last filed 2026-07-28
- 2026-05-31: Finance Lease, Liability $124.79M.
- 2026-02-28: Finance Lease, Liability $44.89M.
- 2025-11-30: Finance Lease, Liability $45.23M.
- 2025-08-31: Finance Lease, Liability $45.55M.
| Period end | Finance Lease, Liability |
|---|---|
| 2026-05-31 | $124.79M 10-K · filed 2026-07-28 |
| 2026-02-28 | $44.89M 10-Q · filed 2026-04-01 |
| 2025-11-30 | $45.23M 10-Q · filed 2026-01-08 |
| 2025-08-31 | $45.55M 10-Q · filed 2025-10-09 |
| 2025-05-31 | $45.85M 10-K · filed 2025-07-29 |
| 2025-02-28 | $46.14M 10-Q · filed 2025-04-08 |
| 2024-11-30 | $46.52M 10-Q · filed 2025-01-10 |
| 2024-08-31 | $44.85M 10-Q · filed 2024-10-10 |
| 2024-05-31 | $45.04M 10-K · filed 2024-07-30 |
| 2024-02-29 | $57.04M 10-Q · filed 2024-04-09 |
| 2023-11-30 | $57.35M 10-Q · filed 2024-01-09 |
| 2021-11-30 | $35.12M 10-Q · filed 2022-01-10 |
| 2021-08-31 | $35.55M 10-Q · filed 2021-10-07 |
| 2021-03-31 | $15.59M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $15.28M 10-K · filed 2021-02-19 |
| 2020-09-30 | $14.49M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $13.21M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $13.21M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $14.15M 10-K · filed 2020-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |